The Efficacy and Safety of Nanoparticle Albumin-bound (NAB)-Paclitaxel Plus Cisolation Versus CEP (Cisplatin, Epirubicin,Cyclophosphamide) in Induction Therapy for Thymoma: a Study for a Single-center Prospective Phase II Randomized Controlled Train.
Clinical trial NCT05816694 · UNKNOWN
Trial details
- NCT number
- NCT05816694
- Sponsor
- Peng Liu
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-04-30
- Primary completion
- 2024-10-30
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.